EUVIMEDEUVIMED entdecken
Fallbericht

Bevacizumab May Overcome Clinical Tumor Drug Resistance to Irinotecan Based Chemotherapy in Patients with Metastatic Colorectal Cancer: Case Report

J.M. Zekri, M.Z. Abubacker

The Open Colorectal Cancer Journal · 2010

DOI: 10.2174/1876820201003010023 ↗

Kurz gefasst

Fallbericht in der Zeitschrift The Open Colorectal Cancer Journal, 2010. Verfasst von J.M. Zekri und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Zekri, J., & Abubacker, M. (2010). Bevacizumab May Overcome Clinical Tumor Drug Resistance to Irinotecan Based Chemotherapy in Patients with Metastatic Colorectal Cancer: Case Report. The Open Colorectal Cancer Journal. https://doi.org/10.2174/1876820201003010023

Vancouver

Zekri J, Abubacker M. Bevacizumab May Overcome Clinical Tumor Drug Resistance to Irinotecan Based Chemotherapy in Patients with Metastatic Colorectal Cancer: Case Report. The Open Colorectal Cancer Journal. 2010. doi:10.2174/1876820201003010023

BibTeX
@article{Zekri2010,
  author = {Zekri, J.M. and Abubacker, M.Z.},
  title = {Bevacizumab May Overcome Clinical Tumor Drug Resistance to Irinotecan Based Chemotherapy in Patients with Metastatic Colorectal Cancer: Case Report},
  journal = {The Open Colorectal Cancer Journal},
  year = {2010},
  doi = {10.2174/1876820201003010023}
}
Kostenlos starten →